The anabolic effect of human PTH (1–34) on bone formation is blunted when bone resorption is inhibited by the bisphosphonate tiludronate—is activated resorption a prerequisite for the in vivo effect of PTH on formation in a remodeling system?
- 30 June 1995
- Vol. 16 (6), 603-610
- https://doi.org/10.1016/8756-3282(95)00113-r
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Effects of combined prostaglandin and alendronate treatment on the histomorphometry and biomechanical properties of bone in ovariectomized ratsJournal of Bone and Mineral Research, 1993
- An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis.Journal of Clinical Investigation, 1993
- Oral tiludronate: Pharmacological properties and potential usefulness in Paget's disease of bone and osteoporosisBone, 1992
- Dose effects on ewe bone remodeling of short-term sodium fluoride administration — A histomorphometric and biochemical studyBone, 1991
- Treatment of osteoporosis with human parathyroid peptide and observations on effect of sodium fluoride.BMJ, 1990
- Restoration of axial and appendicular bone volumes by h-PTH(1–34) in parathyroidectomized and osteopenic ratsBone, 1990
- Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committeeJournal of Bone and Mineral Research, 1987
- Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1–34) and 1,25-dihydroxyvitamin DJournal of Bone and Mineral Research, 1986
- Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss.Journal of Clinical Investigation, 1983
- Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial.BMJ, 1980